Patent ID: 7563763

Claim:
A method for administering follicle stimulating hormone (FSH), the method comprising: providing a pharmaceutical formulation comprising an aqueous diluent, human FSH, and a preservative selected from the group consisting of benzyl alcohol, m-cresol and mixtures thereof, said human FSH consisting of an alpha-subunit having SEQ ID NO:5 and a beta-subunit having SEQ ID NO:6, the alpha-subunit and beta-subunit held together by noncovalent interactions, said human FSH being present as the biologically-active, heterodimeric protein form of human FSH at a concentration of about 5.0 μg/ml to about 200 μg/ml, said preservative being present in said aqueous diluent in an effective anti-microbial amount; injecting a first portion of the pharmaceutical formulation into a human in need of ovarian follicle or testicular stimulation, said injecting a first portion providing an effective dose of biologically active human FSH for ovarian follicle or testicular stimulation in the human; injecting a second portion of the pharmaceutical formulation into said human twenty four hours or greater after said injecting a first portion, said injecting a second portion providing an effective dose of biologically active human FSH for ovarian follicle or testicular stimulation in the human, the formulation having a stability such that each of the first and second portions injected into the human contain a pharmaceutically-effective amount of FSH.